Is individualized medicine for cardiovascular (CV) disease hype or hope? Who should consider bariatric surgery? What are the latest guidelines for managing diabetes? Could erectile dysfunction be a sign of CV disease? These are some of the topics that will be discussed at the 24th Annual R.W. Gunton Symposium on Cardiovascular Therapeutics, organized by Western Univeristy’s Robarts Research Institute.
The symposium takes place Thursday, September 26th from noon to 4:30 p.m. at London Health Sciences Centre, University Hospital, in Auditorium A on the third floor. The event brings together physicians, scientists and trainees to discuss the latest in the treatment of CV disease which remains the leading cause of death worldwide.
The program includes:
12:00 Dr. Michael Strong, Dean, Schulich School of Medicine & Dentistry, welcome
12:10 Dr. Robert Herman, University of Calgary, Grand Rounds Lecture -Resistant hypertension: from bad biology to bad behaviour
1:00 Dr. Rob Hegele, update on managing high cholesterol
1:30 Dr. Charlotte McDonald, newest in diabetes management
2:00 Dr. James Brown, update in CV therapeutics
3:00 Dr. Richard Kim, personalized medicine for CV disease
3:30 Dr. Terri Paul, bariatric surgery, who and how
4:00 Dr. Gerald Brock, erectile dysfunction – a marker for CV disease?
4:30 Dr. Ross Feldman, closing remarks
The event is named for Ramsay W. Gunton, a well-known leader in London’s health care community until his retirement in 1993. After graduating with his medical degree from Western in 1945, Dr. Gunton went on to become the head of Western’s Department of Medicine and was involved in planning both University Hospital and Robarts Research Institute.
If you would like to attend any session, please contact: Kathy Wallis, Media Relations Officer, Schulich School of Medicine & Dentistry, Western University, 519-661-2111 ext. 81136, Kathy.wallis@schulich.uwo.ca
Tags
